Ampio Pharmaceuticals, Inc. (AMPE)

Ampio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash & Equivalents	4.09	6.4	6.95	10.35	12.65	16.95	22.89	28.84	33.89	17.12	20.55	15.8	17.35	9.36	4.84	2.42	6.53	8.04	12.78	5.16
Short-Term Investments	0.03	0.03	0.03	0.03	0.03	0.37	0.37	0.57	0.88	1.04	1.24	1.31	0.27	0.21	0.45	-	1.16	-	-	-
Cash & Short-Term Investments	4.12	6.43	6.99	10.39	12.69	17.31	23.26	29.4	34.78	18.16	21.79	17.12	17.61	9.58	5.3	2.42	7.69	8.04	12.78	5.16
Cash Growth (YoY)	-67.50%	-62.85%	-69.95%	-64.68%	-63.52%	-4.64%	6.75%	71.79%	97.46%	89.61%	311.43%	608.70%	128.91%	19.03%	-58.58%	-53.20%	1.44%	-7.24%	174.17%	-31.39%
Other Receivables	0.92	0.53	1.38	-	-	-	-	0.02	-	0.05	0.03	0.03	0.19	0.01	-	-	0.02	-	-	-
Receivables	0.92	0.53	1.38	-	-	-	-	0.02	-	0.05	0.03	0.03	0.19	0.01	-	-	0.02	-	-	-
Inventory	-	-	-	-	-	-	-	-	0.07	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	-	-	0.05	0.02	-	0.08	0.11	0.09	0.24	-	-	-	-	-	-	0.23	-	0.82	1.63	0.59
Other Current Assets	0.69	0.68	0.73	0.33	0.64	0.93	1.28	0.4	0.55	0.77	1.09	0.46	0.7	1.25	1.49	0.79	0.54	1.01	-	-
Total Current Assets	5.74	7.65	9.15	10.74	13.33	18.32	24.64	29.91	35.63	18.97	22.91	17.6	18.49	10.84	6.79	3.44	8.25	9.88	14.41	5.75
Property, Plant & Equipment	-	-	-	-	0.26	0.52	2.57	2.88	3.19	3.51	3.8	4.12	4.39	4.71	5.07	5.41	5.75	6.08	6.44	6.81
Other Long-Term Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.03	0.03
Total Assets	5.74	7.65	9.15	10.74	13.59	18.84	27.22	32.79	38.83	22.47	26.71	21.73	22.88	15.54	11.86	8.85	14	15.96	20.89	12.59

Liabilities

Fiscal Quarter	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Accounts Payable	0.75	0.46	0.63	0.58	0.1	0.22	0.72	1.58	0.43	0.31	0.17	0.13	0.19	0.4	0.43	1.23	0.15	0.54	1.88	1.28
Accrued Expenses	1.08	1.35	1.42	1.59	0.54	3.29	3.96	3.51	3.89	1.69	2.71	1.16	1.21	1.13	1.75	2.97	3.7	1.59	0.2	0.04
Short-Term Debt	0.18	-	-	-	0.19	-	-	-	0.27	-	-	-	-	-	-	-	-	-	-	-
Current Portion of Leases	0.27	0.36	0.35	0.35	0.34	0.33	0.33	0.32	0.31	0.3	0.3	0.29	0.28	0.28	0.27	0.27	0.26	0.25	0.25	0.24
Other Current Liabilities	0.1	0.1	0.09	0.16	0.03	0.09	0.08	0.11	0.22	0.09	0.05	0.07	0.15	0.12	0.08	0.02	0.18	-	-	-
Total Current Liabilities	2.38	2.27	2.5	2.67	1.19	3.92	5.08	5.53	5.12	2.39	3.24	1.64	1.83	1.92	2.54	4.48	4.28	2.38	2.32	1.56
Long-Term Leases	-	-	0.09	0.19	0.27	0.36	0.45	0.53	0.61	0.69	0.77	0.85	0.93	1	1.07	1.14	1.21	1.28	1.34	1.41
Other Long-Term Liabilities	-	-	-	-	0.33	0.7	1.59	4.47	5.81	2.12	2.34	2.46	2.61	1.9	1.91	1.23	2.06	8.17	6.11	10.09
Total Liabilities	2.38	2.27	2.59	2.86	1.8	4.99	7.12	10.53	11.54	5.2	6.35	4.95	5.37	4.82	5.52	6.85	7.56	11.83	9.78	13.06

Shareholders' Equity

Fiscal Quarter	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Common Stock	-	-	0	0	-	0	0.02	0.02	0	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-In Capital	245.89	245.85	245.8	245.75	245.73	245.57	245.38	245.47	244.88	228.63	228.09	220.95	218.02	206.62	198.87	191.79	191.06	187.74	187.49	176.34
Retained Earnings	-242.53	-240.47	-239.24	-237.87	-233.94	-231.72	-225.31	-223.24	-217.6	-211.38	-207.75	-204.19	-200.53	-195.91	-192.54	-189.81	-184.63	-183.61	-176.39	-176.81
Total Common Equity	3.36	5.38	6.56	7.88	11.79	13.85	20.1	22.25	27.28	17.28	20.36	16.78	17.51	10.73	6.34	1.99	6.44	4.14	11.11	-0.47
Shareholders' Equity	3.36	5.38	6.56	7.88	11.79	13.85	20.1	22.25	27.28	17.28	20.36	16.78	17.51	10.73	6.34	1.99	6.44	4.14	11.11	-0.47
Total Liabilities & Equity	5.74	7.65	9.15	10.74	13.59	18.84	27.22	32.79	38.83	22.47	26.71	21.73	22.88	15.54	11.86	8.85	14	15.96	20.89	12.59

Additional Metrics

Fiscal Quarter	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total Debt	0.45	0.36	0.45	0.53	0.8	0.69	0.77	0.85	1.19	1	1.07	1.14	1.21	1.28	1.34	1.41	1.47	1.53	1.59	1.65
Net Cash (Debt)	3.67	6.07	6.54	9.85	11.88	16.62	22.48	28.55	33.58	17.16	20.71	15.97	16.4	8.3	3.95	1.01	6.23	6.51	11.19	3.51
Net Cash Growth (YoY)	-69.10%	-63.47%	-70.91%	-65.49%	-64.61%	-3.14%	8.54%	78.75%	104.73%	106.76%	424.14%	1484.62%	163.50%	27.38%	-64.69%	-71.30%	-17.93%	-24.88%	140.07%	-53.30%
Net Cash Per Share	4.53	7.67	8.67	13.07	15.77	22.57	31.45	41.38	49.15	26.42	32.81	26.34	28.47	15.14	7.63	2.12	14.24	13.74	23.61	9.48
Filing Date Shares Outstanding	1.14	0.83	0.76	0.76	0.76	0.75	0.75	0.76	0.76	0.67	0.67	0.65	0.65	0.62	0.59	0.55	0.53	0.53	0.47	0.37
Total Common Shares Outstanding	0.83	0.8	0.76	0.76	0.76	0.75	0.75	0.76	0.76	0.67	0.67	0.65	0.64	0.61	0.58	0.53	0.53	0.47	0.47	0.37
Working Capital	3.36	5.38	6.65	8.06	12.14	14.4	19.56	24.38	30.51	16.58	19.67	15.96	16.66	8.92	4.25	-1.04	3.97	7.5	12.09	4.19
Book Value Per Share	4.03	6.68	8.69	10.43	15.61	18.36	26.64	29.39	36.01	25.85	30.53	25.72	27.17	17.49	10.98	3.74	12.18	8.73	23.44	-1.26
Tangible Book Value	3.36	5.38	6.56	7.88	11.79	13.85	20.1	22.25	27.28	17.28	20.36	16.78	17.51	10.73	6.34	1.99	6.44	4.14	11.11	-0.47
Tangible Book Value Per Share	4.03	6.68	8.69	10.43	15.61	18.36	26.64	29.39	36.01	25.85	30.53	25.72	27.17	17.49	10.98	3.74	12.18	8.73	23.44	-1.26
Machinery	-	-	-	-	1.66	1.74	1.74	1.74	1.74	-	-	-	-	-	1.66	1.66	-	1.65	1.65	1.64
Leasehold Improvements	-	-	-	-	4.97	6.36	6.08	6.08	6.08	-	-	-	-	-	6.08	6.08	-	6.08	6.07	6.07

Data Source: S&P Global Market Intelligence Last updated: Mar 27, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error